Many investors have bitter experience with the Glenmark Life Science. Doubting to apply for the Supriya Life Science may not be a wrong one. No harm even in giving it a miss. Thank you.
Krupa ji, GMP may looks like an attractive one. But, the Chances of allotment are bleak. Moreover there are better IPOs in line. Of course, opinions may differ. Nothing wrong in it. Thank you.
29.4. Gujju IPO| Link| Bookmark|
December 14, 2021 9:51:32 AM
Top Contributor (400+ Posts, 100+ Likes)
I think Krupa ji right Price is reasonable and fund available of Map my india to apply in this IPO
Don''t remind me of GLS, I have purchased 100 shares in pre-open @750 in addition to the allotted lot. It is trading around 600+ only. As it is generating profits, I kept it for long term thinking that it may give profit later. If Supriya is also of API, I have to think twice before applying.
Mr. Vijay kumar gopu & Mr. mvsmr I am also affected like you but with little shares only (from ipo only), I am mostly affected from Ashka hospital ipo . Also have other bad ipo’s
Financials, products range & Certifications and Approvals everything seems good. Only catch is price. Second point if China is again allowed to dump, things may go southway. API sector is one where Govt needs to give PLI as protection otherwise it''s very difficult for Indian API industry to survey vecin long run. Let''s hope company pricing is extractive. Otherwise we have a recent example of GLS Life sciences